Current Report Filing (8-k)
October 26 2020 - 4:15PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date
of Report (Date of Earliest Event Reported): October 26, 2020
Trxade
Group, Inc.
(Exact
name of Registrant as specified in its charter)
Delaware
(State
or other jurisdiction of incorporation)
001-39199
|
|
46-3673928
|
(Commission
File
Number)
|
|
(I.R.S.
Employer
Identification
No.)
|
3840
Land O’ Lakes Blvd
Land
O’ Lakes, Florida 34639
(Address
of principal executive offices zip code)
800-261-0281
(Registrant’s
telephone number, including area code)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2. below):
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting material
pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
|
|
Trading
Symbol(s)
|
|
Name
of each exchange on which registered
|
Common
Stock,
$0.00001
Par Value Per Share
|
|
MEDS
|
|
The
NASDAQ Stock Market LLC
(Nasdaq
Capital Market)
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company [X]
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
Item 2.02 Results of Operations and Financial Condition.
On October 26, 2020, Trxade Group, Inc. (“Trxade”
or the “Company”) issued a press release and will hold a conference call and webcast regarding its financial
results for the three months and nine months ended September 30, 2020. A copy of the press release, which includes information
on the conference call and webcast and a summary of such financial results is furnished as Exhibit 99.1 to this Form 8-K.
The information contained
in this Current Report (and included as an exhibit hereto) shall not be deemed “filed” for purposes
of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference
in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific
reference in such a filing.
The press release furnished
as Exhibit 99.1 to this Current Report on Form 8-K, contains forward-looking statements within the safe harbor provisions
under The Private Securities Litigation Reform Act of 1995, and, as such, may involve known and unknown risks, uncertainties and
assumptions. These forward-looking statements relate to the Company’s current expectations and are subject to the limitations
and qualifications set forth in the press release as well as in the Company’s other filings with the Securities and Exchange
Commission, including, without limitation, that actual events and/or results may differ materially from those projected in such
forward-looking statements. These statements also involve known and unknown risks, which may cause the results of the Company,
its divisions and concepts to be materially different than those expressed or implied in such statements. Accordingly, readers
should not place undue reliance on any forward-looking statements. Forward-looking statements may include comments as to the Company’s
beliefs and expectations as to future financial performance, events and trends affecting its business and are necessarily subject
to uncertainties, many of which are outside the Company’s control. More information on potential factors that could affect
the Company’s financial results is included from time to time in the “Forward-Looking Statements,” “Risk
Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations”
sections of the Company’s periodic and current filings with the SEC, including the Form 10-Qs and Form 10-Ks, filed with
the SEC and available at www.sec.gov and in the “NASDAQ:MEDS” — “SEC Filings” section
of the Company’s website at https://www.trxadegroup.com/investors, and specifically including the Company’s
Quarterly Report on Form 10-Q for the quarter ended September 30, 2020. Forward-looking statements speak only as of the date they
are made. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result
of new information, future events or otherwise that occur after that date, except as otherwise provided by law.
Item
9.01 Financial Statements and Exhibits.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
TRXADE GROUP, INC.
|
|
|
|
Date: October 26, 2020
|
By:
|
/s/
Suren Ajjarapu
|
|
Name:
|
Suren Ajjarapu
|
|
Title:
|
Chief Executive Officer
|
EXHIBIT
INDEX
TRxADE Health (NASDAQ:MEDS)
Historical Stock Chart
From Aug 2024 to Sep 2024
TRxADE Health (NASDAQ:MEDS)
Historical Stock Chart
From Sep 2023 to Sep 2024